MHC
REGN icon

Meyer Handelman Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Meyer Handelman Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
2,609
+28
+1% +$19.1K 0.05% 135
2026
Q1 		$1.99M Sell
2,581
-297
-10% -$227K 0.06% 127
2025
Q4 		$2.22M Buy
2,878
+18
+0.6% +$12.2K 0.07% 127
2025
Q3 		$1.61M Sell
2,860
-612
-18% -$346K 0.05% 143
2025
Q2 		$1.82M Sell
3,472
-522
-13% -$291K 0.06% 136
2025
Q1 		$2.53M Sell
3,994
-125
-3% -$86K 0.09% 125
2024
Q4 		$2.93M Sell
4,119
-141
-3% -$118K 0.1% 118
2024
Q3 		$4.48M Sell
4,260
-5
-0.1% -$5.56K 0.15% 107
2024
Q2 		$4.48M Hold
4,265
– – 0.16% 102
2024
Q1 		$4.11M Hold
4,265
– – 0.14% 110
2023
Q4 		$3.75M Buy
4,265
+30
+0.7% +$24.7K 0.15% 110
2023
Q3 		$3.49M Buy
4,235
+435
+11% +$342K 0.14% 114
2023
Q2 		$2.73M Buy
3,800
+225
+6% +$173K 0.11% 124
2023
Q1 		$2.94M Buy
3,575
+70
+2% +$52.8K 0.12% 118
2022
Q4 		$2.53M Sell
3,505
-150
-4% -$111K 0.11% 122
2022
Q3 		$2.52M Buy
3,655
+50
+1% +$31.5K 0.12% 121
2022
Q2 		$2.13M Hold
3,605
– – 0.09% 124
2022
Q1 		$2.52M Buy
3,605
+460
+15% +$291K 0.1% 125
2021
Q4 		$1.99M Buy
3,145
+175
+6% +$108K 0.07% 128
2021
Q3 		$1.8M Hold
2,970
– – 0.07% 127
2021
Q2 		$1.66M Buy
2,970
+725
+32% +$367K 0.07% 134
2021
Q1 		$1.06M Buy
+2,245
New +$1.09M 0.04% 146

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Meyer Handelman Company's REGN Position: Q2 2026 in Review

Meyer Handelman Company increased its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q2 2026, buying an estimated $19.1K and bringing the position to 2,609 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #135.

Meyer Handelman Company first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.48M in Q2 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Meyer Handelman Company held 2,609 shares of Regeneron Pharmaceuticals worth $1.63M as of Q2 2026.
  • Meyer Handelman Company bought 28 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $19.1K.
  • Regeneron Pharmaceuticals made up 0.05% of Meyer Handelman Company's portfolio in Q2 2026, its #135 holding.
  • Meyer Handelman Company first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Meyer Handelman Company's Regeneron Pharmaceuticals position peaked at $4.48M in Q2 2024.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Meyer Handelman Company's 13F filing for Q2 2026, filed 3 Aug 2026.